Key Navy Official Calls for Joint Strategic-Missile Work with Air Force

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
June 17, 2014, 9:26 a.m.

A key Navy lead­er said his ser­vice should co­oper­ate with the Air Force on mod­ern­iz­ing stra­tegic mis­siles to cut costs.

Vice Adm. Terry Be­ne­dict, dir­ect­or of the Navy’s Stra­tegic Sys­tems Pro­gram, in a break­fast speech last week said, “In the past, it’s been, ‘the Navy designs [sub­mar­ine-launched bal­list­ic mis­siles], the Air Force designs [in­ter­con­tin­ent­al bal­list­ic mis­siles], and nev­er shall they talk,’” Break­ing De­fense re­por­ted. “I’m try­ing to break down those walls. … We should be re­quired to talk at the design and de­vel­op­ment phase.”

Be­ne­dict said NASA’s de­cision to end its Space Shuttle pro­gram has had a huge im­pact on the do­mest­ic rock­et-en­gine in­dustry be­cause the space agency was the biggest pur­chaser of sol­id-fuel rock­et boost­ers, which are also used in the Navy’s Tri­dent nuc­le­ar-tipped bal­list­ic mis­siles. As a res­ult, in­dustry prices have ris­en.

The vice ad­mir­al said if the Navy is un­able to per­suade NASA to keep pur­chas­ing sol­id-fuel boost­ers for oth­er space pro­grams it could try to con­vince the Air Force to con­tin­ue us­ing such boost­ers in its up­dated land-based mis­sile force. The Navy can­not switch to a li­quid-fuel mod­el for its mis­siles be­cause the pro­pel­lant is not safe with­in the nar­row con­fines of a sub­mar­ine, ac­cord­ing to the on­line de­fense magazine.

The Air Force is ex­pec­ted by the end of the month to wrap up an “ana­lys­is of al­tern­at­ives” for main­tain­ing a fu­ture ICBM cap­ab­il­ity. The ser­vice has said it will look to “buy the most eco­nom­ic­al and en­dur­ing op­tion” for each com­pon­ent of its up­dated land-based stra­tegic mis­sile.

Be­ne­dict said he would like to see the de­vel­op­ment of a rock­et “pro­pel­lant mix that uses com­mon con­stitu­ents, so that we can get the cost ad­vant­age of bulk buys, and then mix them po­ten­tially in slightly dif­fer­ent for­mu­la­tions [for each user].”

What We're Following See More »
Doesn’t Express Confidence in Marino
Trump to Declare Opioid Emergency Next Week
1 hours ago
THE LATEST

After initially promising it in August, "President Trump said Monday that he will declare a national emergency next week to address the opioid epidemic." When asked, he also "declined to express confidence in Rep. Tom Marino (R-Pa.), his nominee for drug czar, in the wake of revelations that the lawmaker helped steer legislation making it harder to act against giant drug companies."

Source:
INTERVIEW THIS WEEK
Trump Still Considering Yellen For Fed
9 hours ago
THE LATEST

"President Donald Trump plans to formally interview Janet Yellen this week about potentially staying on as Federal Reserve chair, two people familiar with the matter said...Many Republicans on Capitol Hill want Trump to move on from Yellen, whose first term ends in February, and choose a more traditionally conservative Fed chair."

Source:
NOMINEE FOR ONDCP
Trump Noncommittal on Marino
9 hours ago
THE DETAILS
IN LIGHT OF 60 MINUTES REVELATIONS
Manchin Asks Trump to Drop Marino’s Nomination for Drug Czar
10 hours ago
THE LATEST
WOULD OVERTURN MARINO LEGISLATION ON DRUG DISTRIBUTORS
McCaskill Will Introduce Bill in Response to “60 Minutes” Scoop
11 hours ago
THE DETAILS

In the wake of Sunday's blockbuster 60 Minutes/Washington Post report on opioid regulation and enforcement, Sen. Claire McCaskill (D-MO) has introduced legislation that "would repeal a 2016 law that hampered the Drug Enforcement Administration’s ability to regulate opioid distributors it suspects of misconduct." In a statement, McCaskill said: “Media reports indicate that this law has significantly affected the government’s ability to crack down on opioid distributors that are failing to meet their obligations and endangering our communities."

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login